Two Sigma Ventures

insitro

insitro.com

Insitro is a data-driven drug discovery and development company that leverages machine learning and high-throughput biology to transform drug discovery. Founded by Daphne Koller in 2018, the company integrates in vitro cellular data with human clinical data to redefine disease and accelerate the development of new medicines. Insitro's robust machine learning platform enables the identification of therapeutic insights across various diseases, focusing on metabolism, oncology, and neuroscience. By aggregating large, high-quality datasets and fostering a collaborative culture, Insitro aims to bring better drugs faster to patients in need, positioning itself as a leader in innovative drug development.